Lilly supports global Dementia Discovery Fund
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/24/2026
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- Chip stocks plunge, but bargain-hunters limit scale of tech rout
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- Oil prices finish 1% lower as investors focus on Hormuz flows after peace talks
- Needham Starts NeoVolta (NEOV) at Buy
- NextEra to discuss paying about $76 per share for Dominion, Bloomberg News reports
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Campbell Soup (CPB) Declares $0.39 Quarterly Dividend; 7.7% Yield
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
Eli Lilly & Co. (LLY), AstraZeneca (AZN) Extend Immuno-Oncology Collaboration
October 22, 2015 6:21 AM EDTEli Lilly & Co. (NYSE: LLY) and AstraZeneca (NYSE: AZN) announced an extension to their existing immuno-oncology collaboration exploring novel combination therapies for the treatment of patients with solid tumors.
Under the terms of the expanded agreement, Lilly and AstraZeneca will evaluate the safety and efficacy of a range of additional combinations across the companies' complementary portfolios. Lilly will lead the execution of the studies, while both companies will contribute resources. Additional... More
Eli Lilly & Co. (LLY) Will be Key Collaborator in $100M DDF
October 21, 2015 6:34 AM EDTEli Lilly & Co. (NYSE: LLY) announced it will be a key collaborator in the $100 million Dementia Discovery Fund (DDF), which aims to accelerate the discovery and development of new treatments for dementia. This first-ever global dementia research fund recently launched after securing backing from investors including Lilly, the UK Government's Department of Health, Alzheimer's Research UK and a number of other global pharmaceutical companies will invest in research into treatments for the condition.
"Lilly is delighted to be a partner in the Dementia Discovery Fund. Alzheimer's disease is one of... More
